CVS Health raises FY25 adjusted EPS view to $6.30-$6.40 from $6.00-$6.20

Consensus $6.12. The company’s FY25 guidance updates reflect second quarter performance in the Health Care Benefits and Pharmacy & Consumer Wellness segments, partially offset by a decrease in the Health Services segment. “We are encouraged by a second consecutive quarter of solid 2025 results, while we continue to navigate a dynamic environment,” said Brian Newman, CFO of CVS Health (CVS). “As we execute against our strategic priorities, we remain focused on delivering on our financial commitments and advancing initiatives that create long-term value for our stakeholders.”